Search Results

There are 8303 results for: content related to: Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program

  1. Interactions between Simvastatin and Troglitazone or Pioglitazone in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 41, Issue 5, May 2001, Pages: 573–581, Dr. Thomayant Prueksaritanont, Dr. José M. Vega, Dr. Jamie Zhao, Ms. Kathleen Gagliano, Dr. Olga Kuznetsova, Dr. Bret Musser, Mr. Raju D. Amin, Ms. Lida Liu, Dr. Brad A. Roadcap, Ms. Stacy Dilzer, Dr. K. C. Lasseter and Dr. J. Douglas Rogers

    Article first published online : 8 MAR 2013, DOI: 10.1177/00912700122010311

  2. Troglitazone in Type II Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 18, Issue 3, May-June 1998, Pages: 539–548, Nicole Sparano and Terry L. Seaton

    Article first published online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1998.tb03117.x

  3. Thiazolidinediones: a new class of antidiabetic drugs

    Diabetic Medicine

    Volume 16, Issue 3, March 1999, Pages: 179–192, C. Day

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1464-5491.1999.00023.x

  4. A Mechanistic View of Troglitazone Hepatotoxicity

    Hepatotoxicity

    Rawiwan Maniratanachote, Tsuyoshi Yokoi, Pages: 299–311, 2008

    Published Online : 27 FEB 2008, DOI: 10.1002/9780470516751.ch11

  5. Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone

    Diabetic Medicine

    Volume 16, Issue 2, February 1999, Pages: 147–153, M. Buysschaert, E. Bobbioni, M. Starkie, L. Frith and For The Troglitazone Study Group

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1464-5491.1999.00029.x

  6. You have free access to this content
    Involvement of p21WAF1/Cip1, p27Kip1, and p18INK4c in troglitazone-induced cell-cycle arrest in human hepatoma cell lines

    Hepatology

    Volume 33, Issue 5, May 2001, Pages: 1087–1097, Hironori Koga, Shotaro Sakisaka, Masaru Harada, Toshiyuki Takagi, Shinichiro Hanada, Eitaro Taniguchi, Takumi Kawaguchi, Kurumi Sasatomi, Rina Kimura, Osamu Hashimoto, Takato Ueno, Hirohisa Yano, Masamichi Kojiro and Michio Sata

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2001.24024

  7. Drug-Induced Intrahepatic Cholestasis by Interaction with the Hepatic Bile Salt Export Pump (BSEP)

    Hepatotoxicity

    Christoph Funk, Johannes Noé, Renée Portmann, Rubén Alvarez-Sánchez, Florian Klammers, Christiane Lamy, Axel Paehler, Michael Pantze, Pages: 421–446, 2008

    Published Online : 27 FEB 2008, DOI: 10.1002/9780470516751.ch16

  8. Troglitazone Induces G1 Arrest by p27Kip1 Induction That Is Mediated by Inhibition of Proteasome in Human Gastric Cancer Cells

    Japanese Journal of Cancer Research

    Volume 93, Issue 7, July 2002, Pages: 774–782, Shigeru Takeuchi, Toshikatsu Okumura, Wataru Motomura, Miho Nagamine, Nobuhiko Takahashi and Yutaka Kohgo

    Article first published online : 22 AUG 2005, DOI: 10.1111/j.1349-7006.2002.tb01319.x

  9. Lack of Effect of Type II Diabetes on the Pharmacokinetics of Troglitazone in a Multiple-Dose Study

    The Journal of Clinical Pharmacology

    Volume 37, Issue 12, December 1997, Pages: 1114–1120, Dr. Cho-Ming Loi, Dr. Edward J. Randinitis, Dr. Artemios B. Vassos, Dr. David J. Kazierad, Dr. Jeffrey R. Koup and Dr. Allen J. Sedman

    Article first published online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1997.tb04295.x

  10. Meta-Analysis of Steady-State Pharmacokinetics of Troglitazone and Its Metabolites

    The Journal of Clinical Pharmacology

    Volume 37, Issue 11, November 1997, Pages: 1038–1047, Dr. Cho-Ming Loi, Ms. Christine W. Alvey, Dr. Edward J. Randinitis, Dr. Robert Abel, Dr. Malcolm A. Young and Dr. Jeffrey R. Koup

    Article first published online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1997.tb04285.x

  11. Effect of Combination Therapy of Troglitazone and Sulphonylureas in Patients with Type 2 Diabetes Who Were Poorly Controlled by Sulphonylurea Therapy Alone

    Diabetic Medicine

    Volume 13, Issue 4, April 1996, Pages: 365–370, Y. Iwamoto, K. Kosaka, T. Kuzuya, Y. Akanuma, Y. Shigeta and T. Kaneko

    Article first published online : 19 JUL 2004, DOI: 10.1002/(SICI)1096-9136(199604)13:4<365::AID-DIA19>3.0.CO;2-M

  12. You have free access to this content
    Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes

    Hepatology

    Volume 37, Issue 1, January 2003, Pages: 136–147, Shoichiro Shishido, Hironori Koga, Masaru Harada, Hiroto Kumemura, Shinichiro Hanada, Eitaro Taniguchi, Ryukichi Kumashiro, Hiromasa Ohira, Yukio Sato, Masayoshi Namba, Takato Ueno and Michio Sata

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2003.50014

  13. You have free access to this content
    Index

    Hepatotoxicity

    Saura C. Sahu, Pages: 635–682, 2008

    Published Online : 27 FEB 2008, DOI: 10.1002/9780470516751.index

  14. You have free access to this content
    Activation of PPARγ inhibits cell growth and induces apoptosis in human gastric cancer cells

    FEBS Letters

    Volume 455, Issue 1-2, July 16, 1999, Pages: 135–139, Nobuhiko Takahashi, Toshikatsu Okumura, Wataru Motomura, Yoshinori Fujimoto, Isao Kawabata and Yutaka Kohgo

    Article first published online : 15 JUL 1999, DOI: 10.1016/S0014-5793(99)00871-6

  15. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly Type 2 diabetic patients

    Diabetic Medicine

    Volume 15, Issue 9, September 1998, Pages: 772–779, S. Kumar, A. Prange, J. Schulze, S. Lettis and A.H. Barnett

    Article first published online : 19 JUL 2004, DOI: 10.1002/(SICI)1096-9136(199809)15:9<772::AID-DIA677>3.0.CO;2-X

  16. You have free access to this content
    Beneficial effects of troglitazone on neutrophil dysfunction in multiple low-dose streptozotocin-induced diabetic mice

    Clinical & Experimental Immunology

    Volume 137, Issue 2, August 2004, Pages: 263–271, Y. KANNAN, M. TOKUNAGA, M. MORIYAMA, H. KINOSHITA and Y. NAKAMURA

    Article first published online : 16 JUN 2004, DOI: 10.1111/j.1365-2249.2004.02532.x

  17. You have full text access to this Open Access content
    PPARγ ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells

    Cancer Science

    Volume 94, Issue 4, April 2003, Pages: 338–343, Miho Nagamine, Toshikatsu Okumura, Satoshi Tanno, Mitsuko Sawamukai, Wataru Motomura, Nobuhiko Takahashi and Yutaka Kongo

    Article first published online : 19 AUG 2005, DOI: 10.1111/j.1349-7006.2003.tb01443.x

  18. Troglitazone, a Ligand for Peroxisome Proliferator-activated Receptor γ Inhibits Chemically-induced Aberrant Crypt Foci in Rats

    Japanese Journal of Cancer Research

    Volume 92, Issue 4, April 2001, Pages: 396–403, Hiroyuki Kohno, Shin-ichiro Yoshitani, Shigeki Takashima, Ataru Okumura, Masashi Hosokawa, Nobuo Yamaguchi and Takuji Tanaka

    Article first published online : 22 AUG 2005, DOI: 10.1111/j.1349-7006.2001.tb01108.x

  19. The Role of Troglitazone in Treating the Insulin Resistance Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 18, Issue 5, September-October 1998, Pages: 973–987, Dr. Mark C. Granberry, Dr. Eric F. Schneider and Dr. Vivian A. Fonseca

    Article first published online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1998.tb03928.x

  20. Impact of Safety Warnings on Drug Utilization: Marketplace Life Span of Cisapride and Troglitazone

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 8, August 2004, Pages: 978–986, Dr. Julie J. Wilkinson, Dr. Rex W. Force and Dr. Paul S. Cady

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.24.11.978.36136